Literature DB >> 32401176

Expression levels of candidate circulating microRNAs in pediatric tuberculosis.

Kathirvel M1, Saranya S2, Mahadevan S1.   

Abstract

Tuberculosis (TB) is a preventable and curable disease, but increased mortality and morbidity associated with TB is one of the leading causes of deaths worldwide. MicroRNAs (miRNAs) are small, non-coding RNAs known to regulate the host immune response against TB. We investigated the expression profile of candidate circulating miRNAs, which could be used as a blood biomarker for the effective diagnosis of pediatric tuberculosis. A cross-sectional comparative study was conducted, including 30 children with active-TB and 30 healthy controls (HC) in a tertiary care hospital in Puducherry. We used the SYBR green-based miScript qRT-PCR assay to analyze the expression levels of miRNAs in plasma. Further, we used the receiver operating characteristic curve (ROC) to evaluate the diagnostic value of miRNAs. Active-TB included 25 (83.3%) pulmonary TB and 5 (16.7%) extrapulmonary TB cases. We found a significant upregulation of miR-21, miR-29a, miR-31, miR-155, and downregulation of miR-146a in children with active-TB compared to HC. The ROC analysis showed an excellent diagnostic value of miRNAs as follows: miR‑31> miR‑155> miR‑146a with AUC of (95% CI) miRNAs 0.978, 0.953, and 0.903, respectively. Altered circulating miRNA expression levels could be involved in the dysregulation of the host immune response to TB. The ROC analysis indicated that miRNAs miR-31, miR-155 and miR-146a could be effective diagnostic biomarkers for the detection of active-TB in children.

Entities:  

Keywords:  mycobacterium tuberculosis ; TB diagnosis; Tuberculosis; biomarker; microrna; pediatric TB

Mesh:

Substances:

Year:  2020        PMID: 32401176      PMCID: PMC7480566          DOI: 10.1080/20477724.2020.1761140

Source DB:  PubMed          Journal:  Pathog Glob Health        ISSN: 2047-7724            Impact factor:   2.894


  39 in total

1.  Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR.

Authors:  Michael W Pfaffl; Graham W Horgan; Leo Dempfle
Journal:  Nucleic Acids Res       Date:  2002-05-01       Impact factor: 16.971

2.  Diagnostic values of microRNA-31 in peripheral blood mononuclear cells for pediatric pulmonary tuberculosis in Chinese patients.

Authors:  J X Wang; J Xu; Y F Han; Y B Zhu; W J Zhang
Journal:  Genet Mol Res       Date:  2015-12-17

3.  Analysis of microRNA expression profiling identifies miR-155 and miR-155* as potential diagnostic markers for active tuberculosis: a preliminary study.

Authors:  Jing Wu; Chanyi Lu; Ni Diao; Shu Zhang; Sen Wang; Feifei Wang; Yan Gao; Jiazhen Chen; Lingyun Shao; Jingning Lu; Xuelian Zhang; Xinhua Weng; Honghai Wang; Wenhong Zhang; Yuxian Huang
Journal:  Hum Immunol       Date:  2011-10-14       Impact factor: 2.850

4.  Up-regulation of microRNA-155 in macrophages contributes to increased tumor necrosis factor {alpha} (TNF{alpha}) production via increased mRNA half-life in alcoholic liver disease.

Authors:  Shashi Bala; Miguel Marcos; Karen Kodys; Timea Csak; Donna Catalano; Pranoti Mandrekar; Gyongyi Szabo
Journal:  J Biol Chem       Date:  2010-11-09       Impact factor: 5.157

5.  Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21.

Authors:  Frederick J Sheedy; Eva Palsson-McDermott; Elizabeth J Hennessy; Cara Martin; John J O'Leary; Qingguo Ruan; Derek S Johnson; Youhai Chen; Luke A J O'Neill
Journal:  Nat Immunol       Date:  2009-11-29       Impact factor: 25.606

6.  Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells.

Authors:  Marilena P Etna; Alessandro Sinigaglia; Angela Grassi; Elena Giacomini; Alessandra Romagnoli; Manuela Pardini; Martina Severa; Melania Cruciani; Fabiana Rizzo; Eleni Anastasiadou; Barbara Di Camillo; Luisa Barzon; Gian Maria Fimia; Riccardo Manganelli; Eliana M Coccia
Journal:  PLoS Pathog       Date:  2018-01-04       Impact factor: 6.823

Review 7.  miRNAs in Tuberculosis: New Avenues for Diagnosis and Host-Directed Therapy.

Authors:  Naveed Sabir; Tariq Hussain; Syed Zahid Ali Shah; Antonio Peramo; Deming Zhao; Xiangmei Zhou
Journal:  Front Microbiol       Date:  2018-03-29       Impact factor: 5.640

8.  miR-155 inhibition sensitizes CD4+ Th cells for TREG mediated suppression.

Authors:  Heiko F Stahl; Tanja Fauti; Nina Ullrich; Tobias Bopp; Jan Kubach; Werner Rust; Paul Labhart; Vassili Alexiadis; Christian Becker; Mathias Hafner; Andreas Weith; Martin C Lenter; Helmut Jonuleit; Edgar Schmitt; Detlev Mennerich
Journal:  PLoS One       Date:  2009-09-24       Impact factor: 3.240

9.  Foxp3-dependent microRNA155 confers competitive fitness to regulatory T cells by targeting SOCS1 protein.

Authors:  Li-Fan Lu; To-Ha Thai; Dinis Pedro Calado; Ashutosh Chaudhry; Masato Kubo; Kentaro Tanaka; Gabriel B Loeb; Hana Lee; Akihiko Yoshimura; Klaus Rajewsky; Alexander Y Rudensky
Journal:  Immunity       Date:  2009-01-16       Impact factor: 31.745

10.  Decreased expression of miR-21, miR-26a, miR-29a, and miR-142-3p in CD4⁺ T cells and peripheral blood from tuberculosis patients.

Authors:  Katja Kleinsteuber; Kerrin Heesch; Stefanie Schattling; Malte Kohns; Claudia Sander-Jülch; Gerhard Walzl; Anneke Hesseling; Ertan Mayatepek; Bernhard Fleischer; Florian M Marx; Marc Jacobsen
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

View more
  8 in total

1.  MiR-25 blunts autophagy and promotes the survival of Mycobacterium tuberculosis by regulating NPC1.

Authors:  Wenqi Dong; Gaoyan Wang; Jiajia Feng; Pei Li; Rui Wang; Hao Lu; Wenjia Lu; Chenchen Wang; Xiangru Wang; Huanchun Chen; Yaozu Xiang; Chen Tan
Journal:  iScience       Date:  2022-04-22

Review 2.  Epigenetic regulation of pediatric and neonatal immune responses.

Authors:  Jennifer Bermick; Matthew Schaller
Journal:  Pediatr Res       Date:  2021-07-08       Impact factor: 3.756

3.  Profiling the mRNA and miRNA in Peripheral Blood Mononuclear Cells in Subjects with Active Tuberculosis.

Authors:  Dan Cao; Ju Wang; Zhongkang Ji; Yanwan Shangguan; Wanru Guo; Xuewen Feng; Kaijin Xu; Jiezuan Yang
Journal:  Infect Drug Resist       Date:  2020-11-23       Impact factor: 4.003

4.  Micro RNAs as potential biomarkers in tuberculosis: A systematic review.

Authors:  Bijay Pattnaik; Niharika Patnaik; Saurabh Mittal; Anant Mohan; Anurag Agrawal; Randeep Guleria; Karan Madan
Journal:  Noncoding RNA Res       Date:  2022-01-01

5.  Diagnostic value of microRNA-155 in active tuberculosis: A systematic review and meta-analysis.

Authors:  Xiaoyan Li; Jie He; Guodong Wang; Jian Sun
Journal:  Medicine (Baltimore)       Date:  2021-11-19       Impact factor: 1.889

6.  Identification and validation of a T-cell-related MIR600HG/hsa-mir-21-5p competing endogenous RNA network in tuberculosis activation based on integrated bioinformatics approaches.

Authors:  Guo-Hu Hong; Qing Guan; Hong Peng; Xin-Hua Luo; Qing Mao
Journal:  Front Genet       Date:  2022-09-20       Impact factor: 4.772

7.  MicroRNAs as diagnostic biomarkers for Tuberculosis: A systematic review and meta- analysis.

Authors:  Evangeline Ann Daniel; Balakumaran Sathiyamani; Kannan Thiruvengadam; Sandhya Vivekanandan; Hemanathan Vembuli; Luke Elizabeth Hanna
Journal:  Front Immunol       Date:  2022-09-27       Impact factor: 8.786

8.  MicroRNA-23a-3p Down-Regulation in Active Pulmonary Tuberculosis Patients with High Bacterial Burden Inhibits Mononuclear Cell Function and Phagocytosis through TLR4/TNF-α/TGF-β1/IL-10 Signaling via Targeting IRF1/SP1.

Authors:  Yung-Che Chen; Chiu Ping Lee; Chang-Chun Hsiao; Po-Yuan Hsu; Ting-Ya Wang; Chao-Chien Wu; Tung-Ying Chao; Sum-Yee Leung; Yu-Ping Chang; Meng-Chih Lin
Journal:  Int J Mol Sci       Date:  2020-11-14       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.